NYT On Alcor
The New York Times is running an educational article on Alcor, the largest and most well known cryonics provider. "Alcor is a small nonprofit company built on the spectacular wager that it can rescue its patients from natural post-mortem deterioration until a distant time when cellular regeneration, nanotechnology, cloning or some other science can restart their lives, as if the diseases, heart attacks, old age, murders or accidents that concluded their first go-rounds had never happened." It's good to see the cryonics industry getting respectful, serious press; as the article notes, "Alcor knows that the rest of its potential market - that is, almost everyone else - needs an education."
Link: http://www.nytimes.com/2005/02/13/business/yourmoney/13freeze.html?pagewanted=all